eticlopride and Disease Models, Animal

Topics: Animals; Anti-Inflammatory Agents; Chlorpromazine; Cytokines; Disease Models, Animal; Dopamine; Electroacupuncture; Male; Mice; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tumor Necrosis Factor-alpha

Topics: Animals; Attention; Benzazepines; Choline O-Acetyltransferase; Chronobiology Disorders; Circadian Clocks; Circadian Rhythm; Cognition; Disease Models, Animal; Dopamine Antagonists; Female; Gene Expression; Impulsive Behavior; Male; Nicotine; Nicotinic Agonists; Period Circadian Proteins; Rats; Rats, Long-Evans; Reaction Time; Receptors, Dopamine D1; Salicylamides

Topics: Alcohol-Related Disorders; Animals; Behavior, Animal; Conditioning, Classical; Cues; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Drug-Seeking Behavior; Ethanol; Extinction, Psychological; Female; Humans; Male; Rats; Salicylamides; Stereotaxic Techniques; Ventral Tegmental Area

Topics: Action Potentials; Age Factors; Aging; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Brain; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Dose-Response Relationship, Drug; Male; Quinpirole; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Salicylamides; Self Administration; Time Factors; Ventral Tegmental Area

Topics: Amphetamine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Benzazepines; Buspirone; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Mesencephalon; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Receptor Agonists

Topics: Action Potentials; Adrenergic Agents; Animals; Antiparkinson Agents; Basal Ganglia; Brain Waves; Disease Models, Animal; Dopamine Antagonists; Functional Laterality; Levodopa; Male; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Piperazines; Pyridines; Rats; Rats, Long-Evans; Salicylamides; Serotonin Antagonists; Substantia Nigra

Topics: Amisulpride; Animals; Anorexia Nervosa; Benzodiazepines; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Eating; Female; Indoles; Mice; Mice, Inbred BALB C; Motor Activity; Nitriles; Olanzapine; Piperidines; Receptors, Dopamine D3; Salicylamides; Sulpiride; Tetrahydroisoquinolines; Weight Loss

Topics: Amphetamine; Analysis of Variance; Animals; Anorexia; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Feeding Behavior; Male; Rats; Rats, Wistar; Salicylamides; Time Factors

Topics: Action Potentials; Animals; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Light; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Retinal Ganglion Cells; Retinitis Pigmentosa; Salicylamides; Sulpiride

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Cognitive Dysfunction; Corpus Striatum; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Phenotype; Prefrontal Cortex; Psychomotor Disorders; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Sensory Gating; Synaptic Transmission

Topics: Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Electromyography; Laryngeal Diseases; Laryngeal Muscles; Laryngeal Nerves; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Time Factors

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Cataplexy; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Electromyography; Male; Mice; Mice, Knockout; Narcolepsy; Quinpirole; Receptors, Dopamine; Salicylamides; Sleep; Videotape Recording

Topics: Action Potentials; Amino Acids; Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Choice Behavior; Cognition; Disease Models, Animal; Dopamine Antagonists; Excitatory Amino Acid Agonists; Male; Neural Inhibition; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Long-Evans; Salicylamides; Schizophrenic Psychology

Topics: Action Potentials; Amygdala; Analgesics, Opioid; Analysis of Variance; Animals; Benzazepines; Conditioning, Operant; Cyclic AMP; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Male; Memory; Morphine; Nucleus Accumbens; Opioid-Related Disorders; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Opioid; Reward; Salicylamides; Thionucleotides

Topics: Animals; Corpus Striatum; Denervation; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Functional Laterality; Hyperkinesis; Male; Maze Learning; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Statistics, Nonparametric; Time Factors; Vestibule, Labyrinth

Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Survival; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Immunohistochemistry; Male; Microscopy, Electron; Nerve Degeneration; Presynaptic Terminals; Prosencephalon; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Synaptic Transmission; Tyrosine 3-Monooxygenase

Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzazepines; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Male; Neostriatum; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; RGS Proteins; RNA, Messenger; Salicylamides; Signal Transduction